(11S)-2-Bromo-3-oxoeudesmano-12,6-lactone, designated santonin-related compound 2 (SRC2), only weakly affected IB degradation after tumor necrosis factor-(TNF-) stimulation, but strongly blocked the nuclear translocation of nuclear factor B (NF-B) subunit p65. Replacement of Cys-38 of p65 with serine abolished the inhibitory effect of SRC2 on this TNF--induced nuclear translocation. These results indicate that SRC2 inhibits the nuclear translocation of p65 by targeting Cys-38.
Transcription factor nuclear factor B (NF-B) regulates a large number of genes involved in inflammation, immunity, cell survival, cell death, and carcinogenesis.
1) The NF-B family of transcription factors consists of five members: p65 (RelA), RelB, c-Rel, p105/p50, and p100/p52.
2) NF-B dimers, such as the p65/p50 heterodimer, exist as cytoplasmic complexes associated with the inhibitor of NF-B (IB). 2) In the classical NF-B signaling pathway induced by tumor necrosis factor (TNF-) and interleukin-1 (IL-1), TNF receptor 1 and the IL-1 receptor recruit different sets of adaptor proteins to their cytoplasmic domains, and they trigger distinct signaling processes that converge to induce activation of the IB kinase complex as common signaling molecules. 3, 4) The IB kinase complex directly phosphorylates IB, and the phosphorylated IB is immediately ubiquitinated and degraded by the 26S proteasome.
3,4) The NF-B dimers then become free and translocate to the nucleus, where they activate diverse target genes transcriptionally. 1) Sesquiterpene lactones are a large group of secondary metabolites present in many medicinal plants. It has been reported that they exert their anti-inflammatory effects by inhibiting NF-B activation. 5, 6) In our earlier studies, a series of eudesmane-type sesquiterpene lactones, including (11S)-2-bromo-3-oxoeudesmano-12,6-lactone, designated santonin-related compound 2 (SRC2), were synthesized and their immunomodulatory activities were evaluated. [7] [8] [9] Recently, we found that eudesmanetype sesquiterpene lactones inhibit multiple steps in the NF-B signaling pathway induced by TNF-and IL-1 in human lung adenocarcinoma A549 cells. 9) In particular, we found that SRC2 inhibits the nuclear translocation of NF-B subunits p65 and p50 at the earliest step in the TNF--induced NF-B signaling pathway in A549 cells, 9) but the molecular target of SRC2 remains unclear. In this study, we explored further the mechanism of inhibition of SRC2 on the TNF--induced NF-B signaling pathway. Our results indicate that SRC2 selectively inhibits the nuclear translocation of p65 by targeting cysteine 38 (Cys-38).
A549 cells were transiently transfected with an NF-B-responsive luciferase reporter plasmid and NF-B activation was evaluated by reporter assay. TNFinduced NF-B activation 5-to 10-fold in A549 cells (data not shown). SRC2 inhibited NF-B activation in a dose-dependent manner, and almost completely at 100 mM SRC2 in the A549 cells (Fig. 1B) . As reported in our recent paper, 9) translocation of NF-B subunits p65 and p50 to the nucleus in response to TNF-was strongly inhibited by SRC2 in the A549 cells (Fig. 1C) . In the cytoplasm, NF-B subunits p65 and p50 are complexed with IB, which masks their nuclear localization signals. 3, 4) Upon stimulation with TNF-, IB was rapidly phosphorylated within 5-10 min, and then immediately underwent degradation (Fig. 1D) . TNF--induced IB phosphorylation was only weakly affected by SRC2, and a large proportion of IB was hydrolyzed to background levels within 15 min (Fig. 1D) . Thus it appears that a slight delay in the TNF--induced IB degradation by SRC2 causes only weak effects on the inhibition of NF-B nuclear translocation at later time points. Consistently with our recent Biosci. Biotechnol. Biochem., 76 (12), [2360] [2361] [2362] [2363] 2012 Note studies, 9) these data indicate that SRC2 mainly inhibits the translocation of p65 and p50 from the cytoplasm to the nucleus in A549 cells.
To determine whether the inhibitory effect of SRC2 on the TNF--induced NF-B signaling pathway is celltype specific, different cell lines were investigated. Human breast carcinoma MCF-7 cells and human fibrosarcoma HT-1080 cells were pre-incubated with SRC2 for 1 h and then stimulated with TNF-. Whereas NF-B subunits p65 and p50 were barely present in the nucleus in the unstimulated MCF-7 cells and HT-1080 cells, TNF-stimulation induced translocation of p65 and p50 to the nucleus ( Fig. 2A and B) . SRC2 strongly inhibited the TNF--induced nuclear translocation of p65 and p50 in the MCF-7 cells and the HT-1080 cells ( Fig. 2A and B) . In the upstream NF-B signaling pathway, TNF-also induced marked IB degradation within 15 min in the MCF-7 cells and the HT-1080 cells ( Fig. 2C and D) , but 100 mM SRC2 only weakly inhibited TNF--induced IB degradation in the MCF-7 cells and the HT-1080 cells (Fig. 2C and D) . Similar inhibitory profiles of SRC2 as to TNF--induced NF-B nuclear translocation and IB degradation were obtained for human leukemia Jurkat cells (data not shown).
These data clearly indicate that SRC2 inhibits the nuclear translocation of p65 and p50 mainly at the earliest step in the TNF--induced NF-B signaling pathway.
Sesquiterpene lactones that possess ,-unsaturated carbonyl moieties reactive to cysteine thiol groups under Michael-type addition are known to modify the Cys-38 residue of p65 covalently. 5, 6) Cys-38 is a highly conserved residue in the Rel homology domain of p65, and is responsible for DNA binding. 10) Although SRC2 is devoid of ,-unsaturated carbonyl moieties (Fig. 1A) , we hypothesized that it targets Cys-38 in p65 through an -bromo ketone group, which is likely to undergo nucleophilic addition.
A full-length human p65 cDNA was cloned from a cDNA library constructed from A549 cells, and a p65 mutant in which Cys-38 was replaced with serine was constructed by PCR-based site-directed mutagenesis. The N-terminal FLAG-tagged p65(C38S) was subcloned into an expression vector carrying the hygromycinresistance gene as selection marker. A549 cells were transfected with the expression vector encoding FLAGp65(C38S) driven by the SR promoter, and further cultured in the presence of hygromycin (1.2 mg/mL) for approximately 10 d. A549 clones resistant to hygromycin were selected and analyzed by Western blotting using anti-FLAG antibody (Fig. 3A) . Two independently isolated A549 transfectants, designated A549 p65(C38S)#1 and A549 p65(C38S)#2 were found to express FLAG-p65(C38S) at higher and similar levels as compared with endogenous p65, respectively (Fig. 3A) . Wild-type A549 cells and the A549 p65(C38S) transfectants were pre-incubated with SRC2 for 1 h and then stimulated with TNF-for 30 min in the presence of SRC2. SRC2 inhibited the TNF--induced nuclear translocation of p65 and p50 in the wild-type A549 cells and in the A549 p65(C38S) transfectants (Fig. 3B-D) , but SRC2 had weaker inhibitory effects on the TNF--induced nuclear translocation of p65(C38S) than on the endogenous p65 and p50 ( Fig. 3C and D) . These data indicate that SRC2 targets Cys-38 of p65, inhibiting its nuclear localization in response to TNF-.
Sesquiterpene lactones that contain ,-unsaturated carbonyl moieties, and related compounds such as epoxyquinoids that possess epoxide structures, block p65 and IB kinase in the NF-B signaling pathway. 5, 6) It has been found that some of these thiolreactive compounds modify Cys-38 in p65 and Cys-179 in IB kinase . 5, 6) In this study, we found that SRC2 inhibits the TNF--induced nuclear translocation of NF-B at the earliest common step of the NF-B signaling pathway in several human cell lines, and targets the Cys-38 of p65. Thus it seems that SRC2 does not affect IB kinase , but selectively inhibits p65, because IB kinase plays a critical role in the classical NF-B signaling pathway induced by TNF-. 3, 4) It has been shown that the sesquiterpene lactone helenalin selectively alkylates p65 at Cys-38 and inhibits its DNAbinding activity. 11, 12) The epoxyquinoid (À)-dehydroxymethylepoxyquinomicin (DHMEQ) inhibits the nuclear translocation of p65 and subsequent DNA binding of it by covalent modification of Cys-38. 13, 14) These data are consistent with our present finding that SRC2 targets Cys-38 of p65. Nevertheless, in contrast with (À)-DHMEQ which selectively targets Rel homology proteins, including p65, 14) SRC2 may be a more useful bioprobe to elucidate the early NF-B signaling pathway, particularly in response to IL-1, in that it has been shown that SRC2 selectively inhibits IL-1-induced IB phosphorylation or its upstream process.
9) However, it remains unclear whether sesquiterpene lactones and epoxyquinoids target specific cysteine residues and inhibit only limited steps in the NF-B signaling pathway.
In conclusion, in this study, we found that SRC2 selectively inhibits the nuclear translocation of p65 by targeting Cys-38 without affecting the activation of IB kinase in the TNF--induced NF-B signaling pathway. We found recently that eudesmane derivatives, including SRC2, inhibit multiple steps in the NF-B signaling pathway. 9) This study suggests that subtle structural changes in eudesmane derivatives greatly influence the binding and inhibition of target proteins in the NF-B signaling pathway. Other target proteins directly inhibited by eudesmane derivatives should be identified to clarify their mechanisms of inhibition of this pathway.
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